DYAI - Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference | Benzinga
JUPITER, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be attending the following events during the J.P. Morgan 42nd Annual Healthcare Conference in January 2024.
7th Annual BFC Global Healthcare BD and Investment Conference
The St. Regis Hotel, San Francisco, CA
Sunday, January 7, 2024
Presentation time: 3:15 PM PST
Mark Emalfarb, President, and Chief Executive Officer
J.P. Morgan 42nd Annual Healthcare Conference
The Westin St. Francis Hotel, San Francisco, CA
January 8 - 11, 2024
Mr. Emalfarb will be joined by Chief Business Officer, Joe Hazelton, and they will be available for 1:1 meetings during the conferences in San Francisco. Interested parties can request meetings by contacting hzosiak@dyadic.com.
About Dyadic International, Inc.
Dyadic International, Inc. is ...